Skip to main content
OpenTrials
Completed

NCT Number: NCT00353392

Q-Switched Nd:YAG in Macular Amyloidosis

The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Macular Amyloidosis

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Skin Research Center, Shaheed Beheshti Medical University

Tehran, 19899, Iran

About this study

We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Macular amyloidosis confirmed cases

Exclusion criteria

  • Pregnancy and breast feeding
  • Over 18 years old

Treatment and study plan

Laser Therapy

Device

Primary outcomes

  1. Visual and colorimetric assessment

Sponsors and collaborators

Lead sponsor

Shahid Beheshti University of Medical Sciences

Other

Registry information

Important dates

Study start
2006
Primary completion
2006
Study completion
2006
First posted
Jul 18, 2006
Registry last updated
Dec 19, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.